Literature DB >> 2932322

Influence of ranitidine on hepatic blood flow assessed by organ-reflectance spectrophotometer and pulse-Doppler ultrasonic flowmeter.

Y Sasaki, N Hayashi, A Kasahara, Y Matsuda, S Furusawa, H Fusamoto, N Sato, T Kamada.   

Abstract

The influence of the intravenous injection of ranitidine (50 mg) on hepatic hemodynamics was investigated in normal subjects and patients with chronic liver disease. Using the organ-reflectance spectrophotometer, the regional hepatic blood hemoglobin concentration (delta Er569-650), an indicator of the regional hepatic blood flow, and the oxygen saturation of hemoglobin in the regional hepatic tissue (So2) were measured in patients with chronic liver disease after ranitidine injection under peritoneoscopy. With the pulse-Doppler ultrasonic flowmeter, the portal blood flow was measured in patients with chronic liver disease and normal subjects. There were no significant changes in the regional hepatic blood flow, the oxygen saturation of hemoglobin, and the portal blood flow after the intravenous injection of ranitidine. Thus, it is concluded that usual dose of ranitidine has no significant influence on the hepatic blood flow and that it can be prescribed without reducing the hepatic blood flow.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932322     DOI: 10.1007/BF01315601

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery.

Authors:  N TYGSTRUP; K WINKLER; K MELLEMGAARD; M ANDREASSEN
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

2.  Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals.

Authors:  W G SCHENK; J C McDONALD; K McDONALD; T DRAPANAS
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

3.  Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic.

Authors:  J N Cohn; I M Khatri; R J Groszmann; B Kotelanski
Journal:  Am J Med       Date:  1972-12       Impact factor: 4.965

4.  Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.

Authors:  K Kett; E Aadland; A Berstad
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

5.  Gastric inhibitory action of H2-antagonists ranitidine and cimetidine.

Authors:  W Domschke; G Lux; S Domschke
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

6.  Hepatic hemodynamics in patients with chronic hepatitis or cirrhosis as assessed by organ-reflectance spectrophotometry.

Authors:  N Sato; N Hayashi; S Kawano; T Kamada; H Abe
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

Review 7.  A consideration of the adverse effects of cimetidine.

Authors:  J E McGuigan
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

8.  Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents.

Authors:  K V Speeg; R V Patwardhan; G R Avant; M C Mitchell; S Schenker
Journal:  Gastroenterology       Date:  1982-01       Impact factor: 22.682

9.  Oxygen supply to the liver in patients with alcoholic liver disease assessed by organ-reflectance spectrophotometry.

Authors:  N Hayashi; A Kasahara; K Kurosawa; Y Sasaki; H Fusamoto; N Sato; T Kamada
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

10.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20
View more
  5 in total

Review 1.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 2.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

3.  Hepatic blood flow changes in chronic hepatitis C measured by duplex Doppler color sonography: relationship to histological features.

Authors:  K M Walsh; E Leen; R N MacSween; A J Morris
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

4.  Effect of enteral versus parenteral feeding on hepatic blood flow and steady state propofol pharmacokinetics in ICU patients.

Authors:  N Van Brandt; P Hantson; Y Horsmans; P Mahieu; R K Verbeeck
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

Review 5.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.